A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients

EBioMedicine

Volumn 17, Issue , 2017, Pages 157-162

  Shan, Chao ^a   Xie, Xuping ^a   Ren, Ping ^a   Loeffelholz, Michael J ^a   Yang, Yujiao ^a   Furuya, Andrea ^b   Dupuis, Alan P ^b   Kramer, Laura D ^b   Wong, Susan J ^b   Shi, Pei Yong ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b WADSWORTH CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Dengue virus; Flavivirus diagnosis; Neutralization assay; Serologic assay; Zika virus

Indexed keywords

EPITOPE; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY; DIAGNOSTIC KIT;

ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLAVIVIRUS; GOLD STANDARD; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOASSAY; LUCIFERASE ASSAY; PLAQUE ASSAY; PLAQUE REDUCTION NEUTRALIZATION TEST; PRIORITY JOURNAL; RAPID TEST; REPORTER VIRUS BASED NEUTRALIZATION ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; SERODIAGNOSIS; TURNAROUND TIME; VIRUS NEUTRALIZATION; ZIKA FEVER; ANIMAL; BLOOD; CELL LINE; CHLOROCEBUS AETHIOPS; CRICETULUS; DIAGNOSTIC KIT; HAMSTER; IMMUNOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; STANDARDS; VERO CELL LINE;

ANIMALS; ANTIBODIES, NEUTRALIZING; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; CRICETULUS; HUMANS; NEUTRALIZATION TESTS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; VERO CELLS; ZIKA VIRUS INFECTION;

EID: 85014551961     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2017.03.006     Document Type: Article

References (27)

1. Deas, T.S., Binduga-Gajewska, I., Tilgner, M., Ren, P., Stein, D.A., Moulton, H.M., Iversen, P.L., Kauffman, E.B., Kramer, L.D., Shi, P.-Y., Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication. J. Virol. 79 (2005), 4599–4609.
2. Dowd, K.A., Ko, S.Y., Morabito, K.M., Yang, E.S., Pelc, R.S., DeMaso, C.R., Castilho, L.R., Abbink, P., Boyd, M., Nityanandam, R., et al. Rapid development of a DNA vaccine for Zika virus. Science 354 (2016), 237–240.
3. Garcia, G., Vaughn, D.W., Del Angel, R.M., Recognition of synthetic oligopeptides from nonstructural proteins NS1 and NS3 of dengue-4 virus by sera from dengue virus-infected children. Am. J. Trop. Med. Hyg. 56 (1997), 466–470.
4. Hanna, S.L., Pierson, T.C., Sanchez, M.D., Ahmed, A.A., Murtadha, M.M., Doms, R.W., N-linked glycosylation of West Nile virus envelope proteins influences particle assembly and infectivity. J. Virol. 79 (2005), 13262–13274.
5. Harvey, T., Liu, W., Wang, X., Linedale, R., Jacobs, M., Davidson, A., Le, T., Anraku, I., Suhrbier, A., Shi, P., et al. Tetracycline-inducible packaging cell line for production of flavivirus replicon particles. J. Virol. 78 (2004), 531–538.
6. Khromykh, A.A., Varnavski, A.N., Westaway, E.G., Encapsidation of the flavivirus Kunjin replicon RNA by using a complementation system providing Kunjin virus structural proteins in trans. J. Virol. 72 (1998), 5967–5977.
7. Kuno, G., Gubler, D.J., Oliver, A., Use of ‘original antigenic sin’ theory to determine the serotypes of previous dengue infections. Trans. R. Soc. Trop. Med. Hyg. 87 (1993), 103–105.
8. Lanciotti, R.S., Kosoy, O.L., Laven, J.J., Velez, J.O., Lambert, A.J., Johnson, A.J., Stanfield, S.M., Duffy, M.R., Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14 (2008), 1232–1239.
9. Lindenbach, B.D., Murray, C.L., Thiel, H.J., Rice, C.M., Flaviviridae. Knipe, D.M., Howley, P.M., (eds.), sixth ed. Fields Virology, vol. 1, 2013, Lippincott William & Wilkins, Philadelphia, 712–746.
10. Midgley, C.M., Bajwa-Joseph, M., Vasanawathana, S., Limpitikul, W., Wills, B., Flanagan, A., Waiyaiya, E., Tran, H.B., Cowper, A.E., Chotiyarnwong, P., et al. An in-depth analysis of original antigenic sin in dengue virus infection. J. Virol. 85 (2011), 410–421.
11. Musso, D., Gubler, D.J., Zika virus. Clin. Microbiol. Rev. 29 (2016), 487–524.
12. Puig-Basagoiti, F., Deas, T.S., Ren, P., Tilgner, M., Ferguson, D.M., Shi, P.-Y., High-throughput assays using luciferase-expressing replicon, virus-like particle, and full-length virus for West Nile virus drug discovery. Antimicrob. Agents Chemother. 49 (2005), 4980–4988.
13. Samsa, M.M., Mondotte, J.A., Iglesias, N.G., Assuncao-Miranda, I., Barbosa-Lima, G., Da Poian, A.T., Bozza, P.T., Gamarnik, A.V., Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog., 5, 2009, e1000632.
14. Schoggins, J.W., Dorner, M., Feulner, M., Imanaka, N., Murphy, M.Y., Ploss, A., Rice, C.M., Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 14610–14615.
15. Shan, C., Xie, X., Barrett, A.D.T., Garcia-Blanco, M.A., Tesh, R.B., Vasconcelos, P.F.C., Vasilakis, N., Weaver, S.C., Shi, P.Y., Zika virus: diagnosis, therapeutics, and vaccine. ACS Infect. Dis. 2 (2016), 170–172.
16. Shan, C., Xie, X., Muruato, A.E., Rossi, S.L., Roundy, C.M., Azar, S.R., Yang, Y., Tesh, R.B., Bourne, N., Barrett, A.D., et al. An infectious cDNA clone of Zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors. Cell Host Microbe 19 (2016), 891–900.
17. Shi, P.Y., Tilgner, M., Lo, M.K., Kent, K.A., Bernard, K.A., Infectious cDNA clone of the epidemic West Nile virus from New York City. J. Virol. 76 (2002), 5847–5856.
18. Shu, P.Y., Chen, L.K., Chang, S.F., Yueh, Y.Y., Chow, L., Chien, L.J., Chin, C., Lin, T.H., Huang, J.H., Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever. J. Med. Virol. 62 (2000), 224–232.
19. Shu, P.Y., Chen, L.K., Chang, S.F., Yueh, Y.Y., Chow, L., Chien, L.J., Chin, C., Yang, H.H., Lin, T.H., Huang, J.H., Potential application of nonstructural protein NS1 serotype-specific immunoglobulin G enzyme-linked immunosorbent assay in the seroepidemiologic study of dengue virus infection: correlation of results with those of the plaque reduction neutralization test. J. Clin. Microbiol. 40 (2002), 1840–1844.
20. Shustov, A., Mason, P., Frolov, I., Production of pseudoinfectious yellow fever virus with a two-component genome. J. Virol. 81 (2007), 11737–11748.
21. Staples, J.E., Dziuban, E.J., Fischer, M., Cragan, J.D., Rasmussen, S.A., Cannon, M.J., Frey, M.T., Renquist, C.M., Lanciotti, R.S., Munoz, J.L., et al. Interim guidelines for the evaluation and testing of infants with possible congenital Zika virus infection - United States, 2016. MMWR Morb. Mortal. Wkly Rep. 65 (2016), 63–67.
22. Stettler, K., Beltramello, M., Espinosa, D.A., Graham, V., Cassotta, A., Bianchi, S., Vanzetta, F., Minola, A., Jaconi, S., Mele, F., et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353 (2016), 823–826.
23. Taketa-Graham, M., Powell Pereira, J.L., Baylis, E., Cossen, C., Oceguera, L., Patiris, P., Chiles, R., Hanson, C.V., Forghani, B., High throughput quantitative colorimetric microneutralization assay for the confirmation and differentiation of West Nile virus and St. Louis encephalitis virus. Am. J. Trop. Med. Hyg. 82 (2010), 501–504.
24. Wong, S.J., Boyle, R.H., Demarest, V.L., Woodmansee, A.N., Kramer, L.D., Li, H., Drebot, M., Koski, R.A., Fikrig, E., Martin, D.A., et al. An immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections, and form flavivirus vaccination. J. Clin. Microbiol. 41 (2003), 4217–4223.
25. Wong, S.J., Furuya, A., Zou, J., Xie, X., Dupuis, A.P. 2nd, Kramer, L.D., Shi, P.Y., A multiplex microsphere immunoassay for Zika virus diagnosis. EBioMedicine 16:2017 (2017), 136–140.
26. Zhang, P.T., Shan, C., Li, X.D., Liu, S.Q., Deng, C.L., Ye, H.Q., Shang, B.D., Shi, P.Y., Lv, M., Shen, B.F., et al. Generation of a recombinant West Nile virus stably expressing the Gaussia luciferase for neutralization assay. Virus Res. 211 (2016), 17–24.
27. Zou, G., Xu, H.Y., Qing, M., Wang, Q.Y., Shi, P.Y., Development and characterization of a stable luciferase dengue virus for high-throughput screening. Antivir. Res. 91 (2011), 11–19.